Prediction of clinically significant prostate cancer by [ 68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.
Kaan AkcayAli KibarOnur Erdem SahinMuhammet DemirbilekGamze BeydagiSertaç AsaFuad AghazadaTurkay TokluNalan Alan SelcukBülent ÖnalLevent KabasakalPublished in: European journal of nuclear medicine and molecular imaging (2023)
Ga]Ga-PSMA-11 PET/CT imaging is promising for distinguishing high-risk prostate cancer patients from those apt for active surveillance, potentially aiding in the identification of csPCa.